8QQ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abcellera Biologics Inc

Watchlist Manager

Watchlist

Price: 5.65 EUR -4.07% Market Closed

Market Cap: €1.7B

A	Abcellera Biologics Inc F:8QQ	CA
B	Bank Danamon Indonesia Tbk PT XMUN:HX9	ID
A	Alamo Group Inc XBER:AL3	US
I	I-Tail PCL Corp SET:ITC	TH
L	LEG Immobilien SE F:LEG	DE
	A G Barr PLC OTC:BAGFF	UK
	Terns Pharmaceuticals Inc NASDAQ:TERN	US
	Alset AI Ventures Inc OTC:GPUSD	CA
G	Genfit SA SWB:XUP	FR
L	Larimar Therapeutics Inc F:ZA71	US
A	AES Corp XMUN:AES	US
A	Active Biotech AB publ XBER:BTPC	SE
	Osisko Metals Inc F:0B51	CA
A	AES Corp F:AES	US
E	Endesa SA XMUN:ENA	ES
F	Fluor Corp SWB:FLU	US
M	MKS Instruments Inc F:MKT	US
S	Suruga Bank Ltd XMUN:URU	JP
S	Swedish Orphan Biovitrum AB (publ) F:B6E	SE

Profitability Summary

Abcellera Biologics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-289%

Negative 3Y Average Operating Margin

-715%

Declining Operating Margin

-80% > -289%

Negative Net Margin

-195%

Negative 3Y Average Net Margin

-416%

Declining Net Margin

-51% > -195%

Negative Free Cash Flow Margin

-232%

Negative 3Y Average Free Cash Flow Margin

-401%

Declining Free Cash Flow Margin

-130% > -232%

Negative ROE

-14%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-30%

Declining ROIC

-19% > -24%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.